acetylcarnitine has been researched along with Coronary Disease in 9 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carnitine itself was ineffective." | 1.28 | Protective effects of propionyl-L-carnitine during ischemia and reperfusion. ( Paulson, D; Regitz, V; Shug, A; Subramanian, R, 1991) |
| "L-Propionylcarnitine was the most protective agent." | 1.27 | Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation. ( Noonan, J; Paulson, DJ; Schmidt, M; Shug, AL; Traxler, J, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liedtke, AJ | 2 |
| Nellis, SH | 2 |
| Whitesell, LF | 1 |
| Gercken, G | 1 |
| Trotz, M | 1 |
| Katz, AM | 1 |
| Messineo, FC | 1 |
| Shug, AL | 2 |
| Thomsen, JH | 1 |
| Folts, JD | 1 |
| Bittar, N | 1 |
| Klein, MI | 1 |
| Koke, JR | 1 |
| Huth, PJ | 1 |
| Shug, A | 1 |
| Paulson, D | 1 |
| Subramanian, R | 1 |
| Regitz, V | 1 |
| Renstrom, B | 1 |
| Lamers, JM | 1 |
| De Jonge-Stinis, JT | 1 |
| Verdouw, PD | 1 |
| Hülsmann, WC | 1 |
| Hekimian, G | 1 |
| Feuvray, D | 1 |
| Paulson, DJ | 1 |
| Traxler, J | 1 |
| Schmidt, M | 1 |
| Noonan, J | 1 |
9 other studies available for acetylcarnitine and Coronary Disease
| Article | Year |
|---|---|
Effects of regional ischemia on metabolic function in adjacent aerobic myocardium.
Topics: Acetylcarnitine; Acyl Coenzyme A; Animals; Carbon Dioxide; Coronary Circulation; Coronary Disease; E | 1982 |
Fatty acid synthesis in the arrested rabbit heart during ischemia.
Topics: Acetates; Acetylcarnitine; Animals; Coronary Disease; Fatty Acids; Glycerides; Heart Arrest, Induced | 1983 |
Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium.
Topics: Acetylcarnitine; Acyl Coenzyme A; Cell Membrane; Citric Acid Cycle; Coronary Disease; Fatty Acids; F | 1981 |
Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia.
Topics: Acetylcarnitine; Acyl Coenzyme A; Adenosine Triphosphate; Animals; Carnitine; Coenzyme A; Coronary D | 1978 |
Protective effects of propionyl-L-carnitine during ischemia and reperfusion.
Topics: Acetylcarnitine; Acyl Coenzyme A; Animals; Carnitine; Coronary Disease; Hemodynamics; Male; Myocardi | 1991 |
Mechanisms of substrate preference for oxidative metabolism during early myocardial reperfusion.
Topics: Acetyl Coenzyme A; Acetylcarnitine; Animals; Coronary Disease; Fatty Acids; Glycine; Myocardial Repe | 1990 |
On the possible role of long chain fatty acylcarnitine accumulation in producing functional and calcium permeability changes in membranes during myocardial ischaemia.
Topics: Acetylcarnitine; Animals; Calcium; Carnitine; Cell Membrane Permeability; Coronary Disease; Myocardi | 1987 |
Reduction of ischemia-induced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Carnitine; Coronary Disease; Diabetes Mellitus, Ex | 1986 |
Protection of the ischaemic myocardium by L-propionylcarnitine: effects on the recovery of cardiac output after ischaemia and reperfusion, carnitine transport, and fatty acid oxidation.
Topics: Acetylcarnitine; Adenosine Triphosphate; Animals; Blood Pressure; Cardiac Output; Carnitine; Coronar | 1986 |